BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16427306)

  • 1. The ovine nasal mucosa: an alternative tissue site for mucosal immunization.
    Sedgmen BJ; Lofthouse SA; Meeusen EN
    Methods; 2006 Feb; 38(2):112-6. PubMed ID: 16427306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of antigen-specific T- and B-cell memory in local as well as systemic lymphoid tissues following oral immunization with cholera toxin adjuvant.
    Vajdy M; Lycke N
    Immunology; 1993 Oct; 80(2):197-203. PubMed ID: 7505255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
    Elson CO; Ealding W
    J Immunol; 1984 Jun; 132(6):2736-41. PubMed ID: 6233359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal inoculation of Lactobacillus expressing hCGbeta induces an anti-hCGbeta antibody response in mice of different strains.
    Yao XY; Yuan MM; Li DJ
    Methods; 2006 Feb; 38(2):124-32. PubMed ID: 16414267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired mucosal immune responses in interleukin 4-targeted mice.
    Vajdy M; Kosco-Vilbois MH; Kopf M; Köhler G; Lycke N
    J Exp Med; 1995 Jan; 181(1):41-53. PubMed ID: 7807021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal memory B cells retain the ability to produce IgM antibodies 2 years after oral immunization.
    Vajdy M; Lycke N
    Immunology; 1995 Nov; 86(3):336-42. PubMed ID: 8550068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen.
    Elson CO; Ealding W
    J Immunol; 1984 Dec; 133(6):2892-7. PubMed ID: 6491278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-intestinal priming leads to antigen-specific IgA memory cells in peripheral lymphoid organs.
    Jeurissen SH; Claassen E; van Rooijen N; Kraal G
    Immunology; 1985 Nov; 56(3):417-23. PubMed ID: 2416674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal immune features to phosphorylcholine by nasal Flt3 ligand cDNA-based vaccination.
    Baatarjav T; Kataoka K; Gilbert RS; Terao Y; Fukui M; Goto M; Kawabata S; Yamamoto M; Fujihashi K; Ito HO
    Vaccine; 2011 Aug; 29(34):5747-57. PubMed ID: 21683111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization.
    Vajdy M; Lycke NY
    Immunology; 1992 Mar; 75(3):488-92. PubMed ID: 1572696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sheep cannulation model for evaluation of nasal vaccine delivery.
    Yen HH; Scheerlinck JP; Gekas S; Sutton P
    Methods; 2006 Feb; 38(2):117-23. PubMed ID: 16414273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal aluminum (oxy)hydroxide enables adsorbed antigens to induce specific systemic and mucosal immune responses.
    Xu H; Ruwona TB; Thakkar SG; Chen Y; Zeng M; Cui Z
    Hum Vaccin Immunother; 2017 Nov; 13(11):2688-2694. PubMed ID: 28933668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of antibody-secreting cells and antigen-specific T cells in cervical lymph nodes after intranasal immunization.
    Wu HY; Nikolova EB; Beagley KW; Eldridge JH; Russell MW
    Infect Immun; 1997 Jan; 65(1):227-35. PubMed ID: 8975916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal immunization with phosphorylcholine induces antigen specific mucosal and systemic immune responses in mice.
    Tanaka N; Fukuyama S; Fukuiwa T; Kawabata M; Sagara Y; Ito HO; Miwa Y; Nagatake T; Kiyono H; Kurono Y
    Vaccine; 2007 Mar; 25(14):2680-7. PubMed ID: 17270319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques.
    Egan MA; Chong SY; Hagen M; Megati S; Schadeck EB; Piacente P; Ma BJ; Montefiori DC; Haynes BF; Israel ZR; Eldridge JH; Staats HF
    Vaccine; 2004 Sep; 22(27-28):3774-88. PubMed ID: 15315859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcutaneous immunization with phosphorylcholine induces antigen-specific mucosal and systemic immune responses in BALB/c mice.
    Nagano H; Kurono Y
    Auris Nasus Larynx; 2015 Dec; 42(6):478-82. PubMed ID: 26092312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody isotype profiles in serum and circulating antibody-secreting cells following mucosal and peripheral immunisations of sheep.
    Premier RR; Jacobs HJ; Lofthouse SA; Sedgmen BJ; Meeusen EN
    Vet Immunol Immunopathol; 2004 Mar; 98(1-2):77-84. PubMed ID: 15127844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of age and physical activity on the primary in vivo antibody and T cell-mediated responses in men.
    Smith TP; Kennedy SL; Fleshner M
    J Appl Physiol (1985); 2004 Aug; 97(2):491-8. PubMed ID: 15247195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue.
    Hagiwara Y; McGhee JR; Fujihashi K; Kobayashi R; Yoshino N; Kataoka K; Etani Y; Kweon MN; Tamura S; Kurata T; Takeda Y; Kiyono H; Fujihashi K
    J Immunol; 2003 Feb; 170(4):1754-62. PubMed ID: 12574339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal immunity of nasopharynx: an experimental study in TCR-transgenic (OVA23-3) mice.
    Yamada T; Kataoka S; Ogasawara K; Ishimitsu R; Hashigucci K; Suzuki T; Kawauchi H
    Rhinology; 2005 Sep; 43(3):190-8. PubMed ID: 16218512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.